STAT3/Mitophagy Axis Coordinates Macrophage NLRP3 Inflammasome Activation and Inflammatory Bone Loss
- 1 December 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 38 (2) , 335-353
Abstract
Signal transducer and activator of transcription 3 (STAT3), a cytokine-responsive transcription factor, is known to play a role in immunity and bone remodeling. However, whether and how STAT3 impacts macrophage NLR family pyrin domain containing 3 (NLRP3) inflammasome activation associated with inflammatory bone loss remains unknown. Here, STAT3 signaling is hyperactivated in macrophages in the context of both non-sterile and sterile inflammatory osteolysis, and this was highly correlated with the cleaved interleukin-1β (IL-1β) expression pattern. Strikingly, pharmacological inhibition of STAT3 markedly blocks macrophage NLRP3 inflammasome activation in vitro, thereby relieving inflammatory macrophage-amplified osteoclast formation and bone-resorptive activity. Mechanistically, STAT3 inhibition in macrophages triggers PTEN-induced kinase 1 (PINK1)-dependent mitophagy that eliminates dysfunctional mitochondria, reverses mitochondrial membrane potential collapse, and inhibits mitochondrial reactive oxygen species release, thus inactivating the NLRP3 inflammasome. In vivo, STAT3 inhibition effectively protects mice from both infection-induced periapical lesions and aseptic titanium particle-mediated calvarial bone erosion with potent induction of PINK1 and downregulation of inflammasome activation, macrophage infiltration, and osteoclast formation. This study reveals the regulatory role of the STAT3/mitophagy axis at the osteo-immune interface and highlights a potential therapeutic intervention to prevent inflammatory bone loss. © 2022 American Society for Bone and Mineral Research (ASBMR). Abstract Schematic illustration. In both non-sterile and sterile inflammatory osteolysis, macrophage hyperactivated STAT3 is highly correlated with the cleaved IL-1β expression. Targeting STAT3 using stattic blocks macrophage NLRP3 inflammasome activation through triggering PINK1-dependent mitophagy that eliminates dysfunctional mitochondria, thereby relieving inflammatory macrophage-amplified osteoclast formation in vitro and protecting mouse inflammatory osteolysis in vivo.Keywords
Funding Information
- National Natural Science Foundation of China (81771084, 81901000, 81970919, 81970935)
- NSFC
- Fundamental Research Funds for the Central Universities (2042022kf1207)
- National Natural Science Foundation of China (81771084, 81901000, 81970919, 81970935)
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities (2042022kf1207)
This publication has 88 references indexed in Scilit:
- Activation and regulation of the inflammasomesNature Reviews Immunology, 2013
- Treating inflammation by blocking interleukin-1 in a broad spectrum of diseasesNature Reviews Drug Discovery, 2012
- Signal transducer and activator of transcription-3/suppressor of cytokine signaling-3 (STAT3/SOCS3) axis in myeloid cells regulates neuroinflammationProceedings of the National Academy of Sciences, 2012
- Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasomeNature Immunology, 2010
- Diverse Targets of the Transcription Factor STAT3 Contribute to T Cell Pathogenicity and HomeostasisImmunity, 2010
- Expression and regulation of the NALP3 inflammasome complex in periodontal diseasesClinical and Experimental Immunology, 2009
- The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesisNature Immunology, 2009
- Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activityProceedings of the National Academy of Sciences, 2007
- Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systemsNature Reviews Immunology, 2007
- Osteoclast differentiation and activationNature, 2003